IsoRay Inc. | Ownership

Companies that own IsoRay Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
The Vanguard Group, Inc.
1,489,944
2.21%
-15,134
0%
06/30/2018
BlackRock Fund Advisors
869,606
1.29%
2,492
0%
06/30/2018
Geode Capital Management LLC
269,778
0.4%
0
0%
06/30/2018
Bridgeway Capital Management, Inc.
178,500
0.27%
0
0%
06/30/2018
Northern Trust Investments, Inc.
124,577
0.19%
0
0%
06/30/2018
The California Public Employees Retirement System
117,100
0.17%
0
0%
06/30/2018
The Bank of New York Mellon Corp. (Investment Management)
67,416
0.1%
0
0%
06/30/2018
Cahaba Wealth Management, Inc.
55,000
0.08%
0
0.01%
06/30/2018
Crestwood Advisors LLC
54,824
0.08%
0
0%
06/30/2018
Virtu Financial BD LLC
32,111
0.05%
32,111
0%
06/30/2018

About IsoRay

View Profile
Address
350 Hills Street
Richland Washington 99354
United States
Employees -
Website http://www.isoray.com
Updated 07/08/2019
IsoRay, Inc. is a medical technology company. Though its subsidiary IsoRay Medical, Inc., it develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Its product include Cesium-131 (Cs-131), a radioisotope for the treatment of prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma, and pancreatic cancer.